Duke University School of Medicine, Durham, NC, USA.
J Perinatol. 2010 Sep;30(9):604-9. doi: 10.1038/jp.2010.8. Epub 2010 Feb 25.
Premature infants can experience cardiorespiratory events such as apnea after immunization in the neonatal intensive care unit (NICU). These changes in clinical status may precipitate sepsis evaluations. This study evaluated whether sepsis evaluations are increased after immunizations in the NICU.
We conducted a retrospective cohort study of infants older than 53 days who were vaccinated in the NICU at the KPMCP (Kaiser Permanente Medical Care Program). Chart reviews were carried out before and after all immunizations were administered and for all sepsis evaluations after age 53 days. The clinical characteristics of infants on the day before receiving a sepsis evaluation were compared between children undergoing post-immunization sepsis evaluations and children undergoing sepsis evaluation at other times. The incidence rate of sepsis evaluations in the post-immunization period was compared with the rate in a control time period not following immunization using Poisson regression.
A total of 490 infants met the inclusion criteria. The rate of fever was increased in the 24 h period after vaccination (2.3%, P<0.05). The incidence rate of sepsis evaluations was 40% lower after immunization than during the control period, although this was not statistically significant (P=0.09). Infants undergoing a sepsis evaluation after immunization were more likely to have an apneic, bradycardic or moderate-to-severe cardiorespiratory event in the day before the evaluation than were infants undergoing sepsis evaluations at other times (P<0.05).
Despite an increase in fever and cardiorespiratory events after immunization in the NICU, routine vaccination was not associated with increased risk of receiving sepsis evaluations. Providers may be deferring immunizations until infants are clinically stable, or may have a higher threshold for initiating sepsis evaluations after immunization than at other times.
早产儿在新生儿重症监护病房(NICU)接种疫苗后可能会出现呼吸暂停等心肺事件。这些临床状况的变化可能会引发败血症评估。本研究评估了 NICU 接种疫苗后败血症评估是否增加。
我们对在 KPMCP(Kaiser Permanente Medical Care Program)NICU 接种疫苗的 53 天以上婴儿进行了回顾性队列研究。在接种疫苗前后以及 53 天后所有败血症评估前对图表进行了审查。比较了在接受败血症评估前一天接受评估的婴儿的临床特征,这些婴儿在接种疫苗后进行了败血症评估,而其他时间进行了败血症评估。使用泊松回归比较接种后时期与未接种免疫接种的对照时期的败血症评估发生率。
共有 490 名婴儿符合纳入标准。接种后 24 小时内发热率增加(2.3%,P<0.05)。尽管统计学上无显著意义(P=0.09),但接种后败血症评估的发生率比对照期低 40%。与其他时间进行败血症评估的婴儿相比,接种疫苗后进行败血症评估的婴儿在评估前一天更有可能出现呼吸暂停、心动过缓或中重度心肺事件(P<0.05)。
尽管 NICU 接种疫苗后发热和心肺事件增加,但常规接种疫苗与增加接受败血症评估的风险无关。提供者可能会推迟免疫接种,直到婴儿的临床状况稳定,或者在接种疫苗后开始败血症评估的门槛可能比其他时间更高。